Immunostics Co., Inc.

Immunostics Co., Inc. — FDA 510(k) Submissions

Immunostics Co., Inc. has submitted 11 FDA 510(k) premarket notifications since 1984, of which 11 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include System, Test, Rheumatoid Factor, Agglutination Method, Human Chorionic Gonadotropin, Reagent, Occult Blood, System, Test, C-reactive Protein, System, Test, Infectious Mononucleosis . Use the specialty filter in the sidebar to narrow results.